ORAL ANTILIPEMIC||MEDICATION FOR HUMAN USE R-17 ||FIBROLOW||CAPSULES X 30 EACH CAPSULE CONTAINS 200 MG OF FENOFIBRATE
ORAL ANTILIPEMIC||MEDICATION FOR HUMAN USE R-17 ||FIBROLOW||CAPSULES X 30 EACH CAPSULE CONTAINS 200 MG OF FENOFIBRATE
23-September-2022
300490630000
HYPOLIPIDEMIC||MEDICATION FOR HUMAN USE ||FIBROTIN||CAPSULES X 30 EACH CAPSULE CONTAINS 160 MG FINOFIBRATE AND 40 MG PRAVASTATIN
HYPOLIPIDEMIC||MEDICATION FOR HUMAN USE ||FIBROTIN||CAPSULES X 30 EACH CAPSULE CONTAINS 160 MG FINOFIBRATE AND 40 MG PRAVASTATIN
04-January-2023
300490630000
HIPOLIPEMIANTE||MEDICATION FOR HUMAN USE ||FIBROTINA||CAPSULES X 30 EACH CAPSULE CONTAINS 1 60 MG FINOFIBRATE AND 40 MG PRAVASTATIN
HIPOLIPEMIANTE||MEDICATION FOR HUMAN USE ||FIBROTINA||CAPSULES X 30 EACH CAPSULE CONTAINS 1 60 MG FINOFIBRATE AND 40 MG PRAVASTATIN
17-March-2023
300490000200
1 . IBRANCE CAPSULES 1 00 MG 7 CAPSULES EACH 3 BLACK PACKS IN A CARDBOARD BOX SERIES: GL3445 DATE OF MANUFACTURE: 09.06.2022 EXPIRY DATE: 31 . 05. 2025 WITHOUT ALCOHOL
1 . IBRANCE CAPSULES 1 00 MG 7 CAPSULES EACH 3 BLACK PACKS IN A CARDBOARD BOX SERIES: GL3445 DATE OF MANUFACTURE: 09.06.2022 EXPIRY DATE: 31 . 05. 2025 WITHOUT ALCOHOL